| Basics |
Charles River Laboratories International, Inc.
Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.
|
| IPO Date: |
June 23, 2000 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$7.58B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.35 | 1.19%
|
| Avg Daily Range (30 D): |
$2.14 | 1.38%
|
| Avg Daily Range (90 D): |
$3.03 | 2.17%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.53M |
| Avg Daily Volume (30 D): |
.58M |
| Avg Daily Volume (90 D): |
1.05M |
| Trade Size |
| Avg Trade Size (Sh.): |
91 |
| Avg Trade Size (Sh.) (30 D): |
35 |
| Avg Trade Size (Sh.) (90 D): |
46 |
| Institutional Trades |
| Total Inst.Trades: |
13,206 |
| Avg Inst. Trade: |
$3.99M |
| Avg Inst. Trade (30 D): |
$15M |
| Avg Inst. Trade (90 D): |
$11.39M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$8.07M |
| Avg Closing Trade (30 D): |
$28.38M |
| Avg Closing Trade (90 D): |
$32.66M |
| Avg Closing Volume: |
52.58K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.6
|
$.5
|
$-4.19
|
|
Diluted EPS
|
$-.6
|
$.5
|
$-4.17
|
|
Revenue
|
$ 4.02B
|
$ 984.17M
|
$ 1B
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -23.31M
|
$ 25.88M
|
$ -213.75M
|
|
Operating Income / Loss
|
$ 176.04M
|
$ 74.67M
|
$ -167.69M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -106.81M
|
$ 26.16M
|
$ -6.07M
|
|
PE Ratio
|
|
|
|
|
|
|
